LNTH240719C80000
- 37.51
- 0.000.00%
Lantheus Newsroom
B. Riley Adjusts Lantheus Holdings' PT to $146 From $105, Maintains Buy Rating
TD Cowen Remains a Buy on Lantheus (LNTH)
TD Cowen Maintains Lantheus(LNTH.US) With Buy Rating, Raises Target Price to $145
Lantheus Holdings, Inc.'s (NASDAQ:LNTH) P/S Is Still On The Mark Following 48% Share Price Bounce
Russell Rotation: YTD Market Capitalizations Swelling for Small-caps
Lantheus Holdings Is Maintained at Buy by Jones Trading
Lantheus Holdings Price Target Raised to $137.00/Share From $128.00 by Jones Trading
Lantheus Holdings Analyst Ratings
Jefferies Maintains Lantheus(LNTH.US) With Buy Rating, Raises Target Price to $150
Jefferies Reaffirms Their Buy Rating on Lantheus (LNTH)
JonesTrading Maintains Lantheus(LNTH.US) With Buy Rating, Announces Target Price $137
Buy Rating Affirmed for Lantheus Holdings With Enhanced Revenue Projections and Strategic Expansion
Lantheus Holdings Insider Sold Shares Worth $266,417, According to a Recent SEC Filing
Lantheus to Host Second Quarter 2024 Earnings Conference Call and Webcast on July 31, 2024, at 8:00 A.m. Eastern Time
Russell 2000 Marks Fifth Day Of Gains: What's Driving Surge In Small-Cap Stocks?
Lantheus Acquires Meilleur Technologies Gaining Alzheimer's Imaging Agent Candidate
Express News | Lantheus Acquires Meilleur Technologies, Including The NAV-4694 SS Amyloid PET Imaging Agent For Alzheimer's Disease; Financial Terms Not Disclosed
Lantheus Holdings Acquires Meilleur Technologies, Which Includes NAV-4694, Expanding Lantheus' Alzheimer's Disease Pipeline >LNTH
Express News | Lantheus Holdings Inc - Acquires Meilleur Technologies
Express News | Lantheus Holdings Inc - Lantheus Will Make Royalty Payments for Research Revenue and Commercial Sales